Agenus to Report Second Quarter 2014 Financial Results on July 24, 2014; Conference Call to Follow
July 17 2014 - 9:30AM
Business Wire
Agenus Inc. (NASDAQ: AGEN) will release its second quarter 2014
financial results before the market opens on July 24, 2014.
Agenus executives will host a conference call at 11:00 a.m.
Eastern Time that same day. To access the live call, dial
719-325-2362. The call will also be webcast and will be accessible
from the company’s website at www.agenusbio.com/webcast/. A replay
will be available approximately two hours after the call through
midnight Eastern Time on September 24, 2014. The replay number is
416-915-1035, and the access code is 49971. The replay will also be
available on the company’s website approximately two hours after
the live call.
About Agenus
Agenus is an immuno-oncology company developing a portfolio of
checkpoint modulators (CPMs), heat shock protein vaccines and
adjuvants. Agenus’ checkpoint modulator programs target GITR, OX40,
CTLA-4, LAG-3, TIM-3 and PD-1. The company’s proprietary discovery
engine Retrocyte Display® is used to generate fully human
therapeutic antibody drug candidates. The Retrocyte Display
platform uses a high-throughput approach incorporating IgG format
human antibody libraries expressed in mammalian B-lineage cells.
Agenus’ heat shock protein vaccines for cancer and infectious
disease are in Phase 2 studies. The company’s QS-21 Stimulon®
adjuvant platform is extensively partnered with GlaxoSmithKline and
Janssen and includes several candidates in Phase 3 trials. For more
information, please visit www.agenusbio.com, or connect with the
company on Facebook, LinkedIn, Twitter and Google+.
Retrocyte Display and Stimulon are registered trademarks of
Agenus and its subsidiaries.
Media and Investor Contact:Agenus Inc.Jonae R. Barnes,
617-818-2985Vice PresidentInvestor Relations andCorporate
Communicationsjonae.barnes@agenusbio.com
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Jul 2023 to Jul 2024